1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The FiberTAG project: Tagging dietary fibre intake by measuring biomarkers related to the gut microbiota and their interest for health

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The scientific rationale for dietary fibre intake recommendations comes from the recognition of their benefits for health based on studies first published many years ago. It remains unclear which are the key physiological effects generated by dietary fibre in view of the diversity of the food components considered as dietary fibre, of the relevance of their classification (soluble and insoluble) and from the recent discoveries putting forward their interactions with the gut microbiota. The project FiberTAG ( Joint Programming Initiative ‘A Healthy Diet for a Healthy Life’ 2017–2020 https://www.fibertag.eu/) aims to establish a set of biomarkers (markers of gut barrier function and bacterial co‐metabolites including volatile compounds and lipid derivatives), measured in different biological compartments (faeces, blood or breath) linking dietary fibre intake and gut microbiota‐related health effects. The FiberTAG consortium brings together academic and industrial partners from Belgium, France, Germany and Canada to share data and samples obtained from existing as well as new intervention studies in order to evaluate the relevance of such biomarkers. The FiberTAG consortium is currently working on five existing cohorts (prospective observational or nutritional interventions in healthy or obese patients), and a number of new intervention studies to analyse the effect of insoluble dietary fibre (wheat bran and chitin‐glucan, provided by the industrial partners) in healthy individuals or in obese patients at high cardiometabolic risk.

          Related collections

          Most cited references21

          • Record: found
          • Abstract: found
          • Article: not found

          Gut microbiota profiling of pediatric NAFLD and obese patients unveiled by an integrated meta-omics based approach.

          There is evidence that non-alcoholic fatty liver disease (NAFLD) is affected by gut microbiota. Therefore, we investigated its modifications in paediatric NAFLD patients using targeted-metagenomics (MG) and metabolomics (MB). Stools were collected from 61 consecutive patients diagnosed with NAFL, NASH, or obesity and 54 healthy subjects (CTRLs), matched in a case-control fashion. Operational taxonomic units were pyrosequenced targeting 16S ribosomal RNA and volatile organic compounds (VOCs) determined by solid-phase micro-extraction GC-MS. The α-diversity was highest in CTRLs followed by obese, NASH, NAFL patients and β-diversity distinguished between patients and CTRLs, but not NAFL and NASH. Compared to CTRLs, in NAFLD patients Actinobacteria were significantly increased and Bacteroidetes reduced. There were no significant differences amongst NAFL, NASH, and obese groups. Overall NAFLD patients had increased levels of Bradyrhizobium, Anaerococcus, Peptoniphilus, Propionibacterium acnes, Dorea, Ruminococcus and reduced proportions of Oscillospira and Rikenellaceae compared to CTRLs. After reducing MG and MB data dimensionality, multivariate analyses indicated Oscillospira decrease in NAFL and NASH groups, and Ruminococcus, Blautia, and Dorea increase in NASH patients compared to CTRLs. Of the 292 VOCs, 26 were up- and 2 down-regulated in NAFLD patients. Multivariate analyses found that combination of Oscillospira, Rickenellaceae, Parabacteroides, Bacteroides fragilis, Sutterella, Lachnospiraceae, 4-methyl-2-pentanone, 1-butanol, and 2-butanone could discriminate NAFLD patients from CTRLs. Univariate analyses found significantly lower levels of Oscillospira and higher levels of 1-pentanol and 2-butanone in NAFL compared to CTRLs. In NASH, lower levels of Oscillospira were associated with higher abundance of Dorea, Ruminococcus and higher levels of 2-butanone, 4-methyl-2-pentanone compared to CTRLs.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Scientific Opinion on Dietary Reference Values for carbohydrates and dietary fibre

            (2010)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.

              Recent studies have provided new evidence that alterations in the composition of the gut microbiota--known as dysbiosis--participate in the development of obesity. The aim of the present study was to investigate the ability of chitin-glucan (CG) from a fungal source to modulate both the gut microbiota and glucose and lipid metabolism in high-fat (HF) diet-induced obese mice. Supplementation of the HF diet with fungal CG (10% w/w) induced caecal enlargement with prominent changes in gut microbiota: it restored the number of bacteria from clostridial cluster XIVa including Roseburia spp., which were decreased due to HF feeding. Furthermore, CG treatment significantly decreased HF-induced body weight gain, fat mass development, fasting hyperglycemia, glucose intolerance, hepatic triglyceride accumulation and hypercholesterolemia, independently of the caloric intake. All those parameters were negatively correlated with specific bacteria of clostridial cluster XIVa, i.e., Roseburia spp. (Pearson's correlations analysis). In contrast to prebiotics that more specifically target the bifidobacteria species, CG effects on obesity appear to be independent of the incretin glucagon-like peptide 1 (GLP-1) production, since portal GLP-1 and proglucagon (its precursor) expression were not modified by the dietary intervention. In conclusion, our findings support the view that chronic consumption of CG has potential beneficial effects with respect to the development of obesity and associated metabolic diabetes and hepatic steatosis, through a mechanism related to the restoration of the composition and/or the activity of gut bacteria, namely, bacteria from clostridial cluster XIVa. Copyright © 2012 Elsevier Inc. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                nathalie.delzenne@uclouvain.be
                Journal
                Nutr Bull
                Nutr Bull
                10.1111/(ISSN)1467-3010
                NBU
                Nutrition Bulletin
                John Wiley and Sons Inc. (Hoboken )
                1471-9827
                1467-3010
                05 February 2020
                March 2020
                : 45
                : 1 ( doiID: 10.1111/nbu.v45.1 )
                : 59-65
                Affiliations
                [ 1 ] Metabolism and Nutrition Research Group Louvain Drug Research Institute UCLouvain Université Catholique de Louvain Brussels Belgium
                [ 2 ] Mondelez Int. R&D Saclay France
                [ 3 ] KitoZyme S.A Herstal Belgium
                [ 4 ] Department of Agricultural Food & Nutritional Science and Department of Biological Sciences University of Alberta Edmonton AB Canada
                [ 5 ] Institute of Nutritional Medicine University of Hohenheim Stuttgart Germany
                [ 6 ] Centre de Recherche en Nutrition Humaine Rhône‐Alpes Univ‐Lyon Université Claude Bernard Lyon Hospices Civils de Lyon CENS FCRIN/FORCE Network CarMeN Laboratory Lyon France
                Author notes
                [*] [* ] Correspondence: Prof. Nathalie M. Delzenne, President, Louvain Drug Research Institute, Université catholique de Louvain, Avenue E. Mounier 73 bte B1 73.06, 1200 Brussels, Belgium.

                E‐mail: nathalie.delzenne@ 123456uclouvain.be

                Author information
                https://orcid.org/0000-0003-2115-6082
                Article
                NBU12416
                10.1111/nbu.12416
                7074038
                2a8575f9-ff1b-42d3-b185-40bac5a15f71
                © 2020 The Authors. Nutrition Bulletin published by John Wiley & Sons Ltd on behalf of British Nutrition Foundation

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 26 November 2019
                : 18 December 2019
                : 02 January 2020
                Page count
                Figures: 1, Tables: 1, Pages: 7, Words: 4703
                Funding
                Funded by: Agence Nationale de la Recherche , open-funder-registry 10.13039/501100001665;
                Funded by: Service Public de Wallonie , open-funder-registry 10.13039/501100009595;
                Award ID: 1610365
                Funded by: Bundesministerium für Bildung und Forschung , open-funder-registry 10.13039/501100002347;
                Funded by: Canadian Institutes of Health Research , open-funder-registry 10.13039/501100000024;
                Categories
                Emerging Research
                Emerging Research
                Custom metadata
                2.0
                March 2020
                Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.7 mode:remove_FC converted:11.03.2020

                Nutrition & Dietetics
                biomarkers,chitin‐glucan,dietary fibre,exhaled volatile organic compounds,microbiota,wheat bran

                Comments

                Comment on this article